Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Workshop Series to identify, discuss and develop recommendations for the optimal generation and use of in vitro assay data for tobacco product regulation.

Award Number: R13FD007816
ORGANIZATION: FOOD AND DRUG ADMINISTRATION
OPDIV: FDA
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2023
PERIOD OF PERFORMANCE END DATE: 10/31/2024

Group Awards By:

View Award Description

Workshop Series to identify, discuss and develop recommendations for the optimal generation and use of in vitro assay data for tobacco product regulation. - Project Summary/Abstract Research priorities for the Center for Tobacco Products (CTP) include “Evaluation of toxicity from exposures to complex mixtures of tobacco-related constituents in ENDS aerosol, waterpipe smoke, cigar smoke, and smokeless tobacco using toxicological assays such as in vivo, in silico, as well as in vitro models that are more physiologically relevant to humans.” Although CTP regulatory guidance documents include genotoxicity and other in vitro assays in the types of toxicity information required for submissions, there is no standardized guidance or regulatory approved methods for the evaluation of various tobacco products, including ENDS. Therefore, the Institute for In Vitro Sciences (IIVS), a 501(c)(3) nonprofit organization, has organized a Workshop Series to identify, discuss and develop recommendations for the best scientific/technical approaches for generating and interpreting in vitro assay data for comparing toxicity within and across tobacco product classes. Designed as true working meetings, expert stakeholders will discuss and develop recommendations that will then be published. The initial focus of the series (2018 – 2022) has been on the use of the regulatory genetic toxicology assays (Ames test, in vitro mammalian assays for cytogenetic damage and gene mutation) with various types of tobacco and nicotine products. Going forward we will finalize recommendations for the use of the genetic toxicology assays and transition to an emphasis on human in vitro models of potential target tissue, some of which can be utilized as disease models. These workshops provide a unique opportunity for multiple stakeholders to share their expertise and will provide published resources that regulatory agencies, academic laboratories, and industry may use as they address the public health issues related to the use of tobacco products. Some of workshop reports may serve as authoritative publications that can be referenced for optimal methodologies and data interpretation. So far, the workshops (1-7) have identified important issues for using in vitro assays for evaluating tobacco products and have focused on several of CTP’s high-priority topics. Multiple working groups have been established to collect background information, to hold discussions between workshops, and to develop recommendations that are discussed during the workshops. Multiple sets of recommendations have resulted from these workshops. Three manuscripts have been published, one is in press, and seven are in preparation. Final recommendations for using the Ames assay to compare within and between various tobacco and nicotine containing products will be addressed in Workshop 8 (February 2023). Workshop 9 (June 2023) will focus on: 1) oral tobacco and nicotine products (chemistry and in vitro methods), and 2) approaches for evaluating both general toxicity and disease- causing potential of tobacco products using human 3-D tissue models.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2023	INSTITUTE FOR INVITRO SCIENCES INC	30 W WATKINS MILL RD	GAITHERSBURG	MD	20878	MONTGOMERY	USA	Food and Drug Administration Research	001	1	1/23/2024	NEW	$0
2024	2023	INSTITUTE FOR INVITRO SCIENCES INC	30 W WATKINS MILL RD	GAITHERSBURG	MD	20878	MONTGOMERY	USA	Food and Drug Administration Research	000	1	1/16/2024	NEW	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $49,999 )
2023	2023	INSTITUTE FOR IN VITRO SCIENCES	30 W WATKINS MILL RD STE 100	GAITHERSBURG	MD	20878	MONTGOMERY	USA	Food and Drug Administration Research	000	1	2/7/2023	NEW	$49,999
														Subtotal = $49,999

Grand Total All Awards = $49,999

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Workshop Series to identify, discuss and develop recommendations for the optimal generation and use of in vitro assay data for tobacco product regulation.

Award Number: R13FD007816

ORGANIZATION: FOOD AND DRUG ADMINISTRATION

OPDIV: FDA

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2023

PERIOD OF PERFORMANCE END DATE: 10/31/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer